You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先健科技控股子公司元心科技引入战略投资
格隆汇 11-25 22:32

2020年11月25日,先健科技旗下专注于医用生物可吸收金属材料产品的研究、开发、制造及销售的控股子公司——元心科技(深圳)有限公司(“元心科技”),顺利引入了包括IDG资本、基石投资在内的多家战略投资者,并已完成增资协议和股东协议的签署。本次A轮新入投资者将按增资协议的约定合计向元心科技增资人民币1.6亿元,对应元心科技增资扩股后约13.19%的股权。交易完成后,先健科技仍对元心科技绝对控股。

元心科技的铁基生物可吸收材料平台已历经十余年稳健发展,是全球生物可吸收支架领域的创新者和领跑者。本次获得A轮战略融资,是元心科技发展的重要里程碑,将为其后续发展带来必要的资金支持,进一步有效地激励铁基项目团队及吸收外部人才,加速铁基项目的临床及上市审批进程。元心科技将高效利用资金,积极整合内外优势资源,同时进一步丰富现有产品组合,推进业务的全面可持续发展,为全球患者带来突破性的临床治疗方案。同时,本次融资拉开了元心科技于资本市场独立融资运作的序幕,行业领先的战略投资者的加入将更好地助力元心科技的后续融资及资本化运作,进而提升元心科技及先健集团的整体价值。

元心科技是全球唯一从事铁基可吸收支架研发的企业,具有先进的科研条件和高水平的研发团队,致力于研发优秀的创新介入器械产品服务于广大患者,解决全球未被满足的临床需求。元心科技全球首创的铁基生物可吸收材料平台,在医疗领域具有广泛的应用空间和拓展潜力,目前已成功开发多款全降解铁基生物可吸收支架产品,应用于冠心病、儿童肺血管狭窄和膝下动脉狭窄等多个主流业务领域。三款核心产品正处于临床和市场准入的不同阶段,均已获批进入国家创新医疗器械特别审查程序,目前各项工作推进顺利,将为相关疾病的有效治疗带来重大突破。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account